Lv21
102 积分 2023-03-27 加入
Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature
2个月前
已完结
Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study
2个月前
已完结
Adverse Prognostic Significance of KIT Mutations in Adult Acute Myeloid Leukemia With inv(16) and t(8;21): A Cancer and Leukemia Group B Study
2个月前
已完结
Streamline: Retrospective Cohort Study of FMS-Like Tyrosine Kinase 3-Mutated Acute Myeloid Leukemia – Real-World Treatment Patterns and Clinical Outcomes of Patients in First Relapse or Refractory Diagnosis
6个月前
已完结
Gilteritinib‐based combination therapy in adult relapsed/refractory FLT3 ‐mutated acute myeloid leukaemia
6个月前
已完结
SOHO State of the Art Updates and Next Questions Acute Myeloid Leukemia: Current Status and Next Questions
6个月前
已完结
Gilteritinib: A Review in Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukaemia
7个月前
已完结
Efficacy of FLT3 and IDH1/2 inhibitors in patients with acute myeloid leukemia previously treated with venetoclax
7个月前
已完结
Outcomes with molecularly targeted agents as salvage therapy following frontline venetoclax + hypomethylating agent in adults with acute myeloid leukemia: A multicenter retrospective analysis
7个月前
已关闭
Contemporary Management of Acute Myeloid Leukemia
7个月前
已完结
皖公网安备34019202002308
